Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Front-line”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT02079220
What this trial is testing

A Phase II Study of Ziv-aflibercept in Combination With Capecitabine/Oxaliplatin (XELOX) Chemotherapy in the Front-Line Treatment of Patients With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
James J Lee
Testing effectiveness (Phase 2)Ended earlyNCT02898259
What this trial is testing

Lenalidomide, Ixazomib, and Rituximab as Front-Line Therapy for High Risk Indolent B-Cell Lymphoma

Who this might be right for
B Cell LymphomaLymphoma
Brian Hill 19
Testing effectiveness (Phase 2)Active Not RecruitingNCT04736173
What this trial is testing

Study Evaluating Effectiveness and Safety of Zimberelimab and Domvanalimab in Lung Cancer

Who this might be right for
Non Small Cell Lung CancerNonsquamous Non Small Cell Lung CancerSquamous Non Small Cell Lung Cancer+1 more
Arcus Biosciences, Inc. 169
Testing effectiveness (Phase 2)Study completedNCT00051493
What this trial is testing

ALIMTA Plus Carboplatin as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial.

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Eli Lilly and Company 50
Large-scale testing (Phase 3)Study completedNCT00046683
What this trial is testing

Efficacy/Safety of Frontline Alemtuzumab (Campath, MabCampath) vs Chlorambucil in Patients With Progressive B-Cell Lymphocytic Leukemia

Who this might be right for
B Cell Chronic Lymphocytic Leukemia
Genzyme, a Sanofi Company 284
Testing effectiveness (Phase 2)Active Not RecruitingNCT04416451
What this trial is testing

A Phase II Study Using Rituximab Plus Venetoclax in the Front Line Treatment of Marginal Zone Lymphoma

Who this might be right for
Marginal Zone Lymphoma
Memorial Sloan Kettering Cancer Center 6
Testing effectiveness (Phase 2)Study completedNCT02713386
What this trial is testing

Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid AdenocarcinomaFallopian Tube High Grade Serous Adenocarcinoma+23 more
NRG Oncology 147
Not applicableStudy completedNCT01788995
What this trial is testing

BOVARI: A Non-Interventional Study of Avastin (Bevacizumab) as Front-Line Treatment in Patients With Ovarian Cancer

Who this might be right for
Ovarian Cancer, Peritoneal Neoplasms
Hoffmann-La Roche 63
Testing effectiveness (Phase 2)Study completedNCT03113422
What this trial is testing

Phase II Venetoclax, Obinutuzumab and Bendamustine in High Tumor Burden Follicular Lymphoma as Front Line Therapy

Who this might be right for
Follicular LymphomaNon-Hodgkin's Lymphoma FollicularNon-Hodgkin's Lymphoma, Adult High Grade
PrECOG, LLC. 56
Early research (Phase 1)Active Not RecruitingNCT03770429
What this trial is testing

AZD6738 for Patients With Progressive MDS or CMML

Who this might be right for
LeukemiaMyelodysplastic Syndrome
Massachusetts General Hospital 52
Not applicableUnknownNCT01862445
What this trial is testing

Retrospective Study: Efficacy and Safety of Chlorambucil + Rituximab in CLL Patients

Who this might be right for
CLLB-cellSmall Lymphocytic Lymphoma+2 more
Gruppo Italiano Malattie EMatologiche dell'Adulto 100
Not applicableStudy completedNCT04304690
What this trial is testing

COVID-19 Seroconversion Among Front Line Medical and Paramedical Staff in Emergency, Intensive Care Units and Infectious Disease Departments During the 2020 Epidemic

Who this might be right for
Sars-CoV2
Assistance Publique - Hôpitaux de Paris 1,177
Testing effectiveness (Phase 2)Study completedNCT02405364
What this trial is testing

Front-line Therapy With Carfilzomib, Lenalidomide, and Dexamethasone Induction

Who this might be right for
Multiple Myeloma
University Hospital, Toulouse 46
Testing effectiveness (Phase 2)UnknownNCT05372198
What this trial is testing

Surufatinib With or Wothout Immunotherapy for Advanced Colorectal Cancer in Later Line

Who this might be right for
Colorectal Neoplasms
Hubei Cancer Hospital 50
Testing effectiveness (Phase 2)Study completedNCT01444716
What this trial is testing

Ofatumumab as Front-Line Therapy in Treating Elderly Participants With Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
M.D. Anderson Cancer Center 34
Testing effectiveness (Phase 2)WithdrawnNCT04045730
What this trial is testing

The Study of Gemcitabine Plus Nab-Paclitaxel in Combination With Pegvorhyaluronidase Alfa (PVHA; PEGPH20) and Pembrolizumab as Front-line Treatment for Metastatic Pancreatic Adenocarcinoma.

Who this might be right for
Pancreas Adenocarcinoma
Yale University
Not applicableUnknownNCT01229306
What this trial is testing

Repeat Ablation Procedure in Patients With Relapse of Atrial Fibrillation

Who this might be right for
AblationParoxysmal Atrial Fibrillation
Deutsches Herzzentrum Muenchen 108
Testing effectiveness (Phase 2)Looking for participantsNCT06736613
What this trial is testing

Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma

Who this might be right for
Diffuse Large B Cell LymphomaHigh-grade B-cell LymphomaStage III High Grade B-Cell Lymphoma+7 more
Memorial Sloan Kettering Cancer Center 50
Large-scale testing (Phase 3)Active Not RecruitingNCT03522246
What this trial is testing

A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy

Who this might be right for
Epithelial Ovarian CancerPrimary PeritonealFallopian Tube Cancer+4 more
pharmaand GmbH 1,097
Not applicableStudy completedNCT06235047
What this trial is testing

Liposomal Doxorubicin-containing Front-line Treatment in Elderly Patients With HL (HL-MVD)

Who this might be right for
Classic Hodgkin Lymphoma
Federico II University 60
Next Page